Anticraving therapy for alcohol use disorder: A clinical review.

Author: ShenWinston W

Paper Details 
Original Abstract of the Article :
AIM: In this review, the author focused on anticraving therapy for alcohol use disorder (AUD) defined by DMS-5. A comprehensive review was carried out on the available published papers on anticraving drugs for treating AUD patients. METHODS: The author described all drugs with anticraving benefits ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292332/

データ提供:米国国立医学図書館(NLM)

Anticraving Therapy: A Beacon of Hope in the Desert of Alcohol Use Disorder

Alcohol use disorder (AUD) is a challenging condition that can feel like a relentless sandstorm, sweeping away an individual's health and well-being. Researchers are constantly searching for oases of knowledge to guide them in developing more effective treatments for AUD, particularly those that target cravings. This study examines the current state of anticraving therapy for AUD, providing a comprehensive overview of available medications.

Finding Relief in the Desert of Cravings

The researchers, like seasoned explorers searching for a rare desert plant with medicinal properties, reviewed a vast body of research on anticraving medications for AUD. They identified a number of FDA-approved medications, including acamprosate, naltrexone, gamma-hydroxybutyrate, and nalmefene. They also highlighted promising medications under development, such as topiramate, gabapentin, ondansetron, and others. This extensive review provides a valuable resource for healthcare professionals who are seeking to help individuals struggling with AUD.

Navigating the Path to Recovery

This study provides a clear roadmap for navigating the desert of AUD treatment. The availability of a range of anticraving medications offers a beacon of hope for individuals seeking to manage their cravings and achieve recovery. It's a reminder that just as a camel can navigate the vast and unforgiving desert, so too can individuals find strength and support in their journey towards recovery. Remember, seeking help is a sign of strength, not weakness.

Dr.Camel's Conclusion

This study provides a comprehensive overview of the promising field of anticraving therapy for alcohol use disorder. The research highlights the availability of FDA-approved medications and promising medications under development, offering a glimmer of hope for individuals seeking to manage their cravings and achieve recovery. Just as a camel adapts to the harsh desert environment, so too can individuals find ways to navigate the challenges of AUD with the help of appropriate treatment options and support systems.

Date :
  1. Date Completed 2019-09-18
  2. Date Revised 2020-12-09
Further Info :

Pubmed ID

30175522

DOI: Digital Object Identifier

PMC7292332

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.